SG Americas Securities’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-10,786
| Closed | -$1.63M | – | 3097 |
|
2022
Q3 | $1.63M | Sell |
10,786
-9,396
| -47% | -$1.42M | 0.02% | 573 |
|
2022
Q2 | $2.94M | Buy |
20,182
+8,714
| +76% | +$1.27M | 0.03% | 444 |
|
2022
Q1 | $1.36M | Sell |
11,468
-8,210
| -42% | -$974K | 0.01% | 1060 |
|
2021
Q4 | $2.71M | Sell |
19,678
-336
| -2% | -$46.3K | 0.01% | 767 |
|
2021
Q3 | $2.78M | Buy |
20,014
+10,709
| +115% | +$1.49M | 0.01% | 886 |
|
2021
Q2 | $903K | Buy |
9,305
+472
| +5% | +$45.8K | ﹤0.01% | 1469 |
|
2021
Q1 | $604K | Sell |
8,833
-1,823
| -17% | -$125K | ﹤0.01% | 1713 |
|
2020
Q4 | $913K | Sell |
10,656
-3,327
| -24% | -$285K | ﹤0.01% | 1388 |
|
2020
Q3 | $909K | Buy |
13,983
+6,252
| +81% | +$406K | 0.01% | 1027 |
|
2020
Q2 | $565K | Sell |
7,731
-22,097
| -74% | -$1.61M | ﹤0.01% | 1688 |
|
2020
Q1 | $1.02M | Buy |
29,828
+27,596
| +1,236% | +$939K | 0.01% | 1018 |
|
2019
Q4 | $122K | Buy |
+2,232
| New | +$122K | ﹤0.01% | 2439 |
|
2019
Q2 | – | Sell |
-11,196
| Closed | -$576K | – | 3093 |
|
2019
Q1 | $576K | Sell |
11,196
-2,501
| -18% | -$129K | 0.01% | 1507 |
|
2018
Q4 | $507K | Buy |
+13,697
| New | +$507K | ﹤0.01% | 1588 |
|
2018
Q3 | – | Sell |
-4,826
| Closed | -$191K | – | 3096 |
|
2018
Q2 | $191K | Buy |
+4,826
| New | +$191K | ﹤0.01% | 2293 |
|